1 week Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Tops Revenue Estimates Zacks

Vanda (VNDA) delivered earnings and revenue surprises of 42.86% and 4.28%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?